XOM
50
-4
AMT
29
-10
ZBH
62
-6
TGNA
56
-2
AES
55
-7
GILD
55
5
WMT
58
-4
NUE
62
-3
PEP
29
-3
FOXA
63
-3
DAL
70
-2
LEN
21
-2
EMC
67
-7
KSS
64
-7
NTRS
65
-2
SE
69
-3
R
68
-4
URBN
66
-2
GRMN
42
2
EQT
56
6
XOM
50
-4
AMT
29
-10
ZBH
62
-6
TGNA
56
-2
AES
55
-7
GILD
55
5
WMT
58
-4
NUE
62
-3
PEP
29
-3
FOXA
63
-3
DAL
70
-2
LEN
21
-2
EMC
67
-7
KSS
64
-7
NTRS
65
-2
SE
69
-3
R
68
-4
URBN
66
-2
GRMN
42
2
EQT
56
6
Financhill
Back

Nuveen Real Estate Income Fund Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Buy
52

JRS
Nuveen Real Estate Income Fund

Last Price:
$7.64
Seasonality Move:
1.27%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.22
Seasonality Move:
-13.28%
Buy
52
Nuveen Real Estate Income Fund (JRS) is a Buy

Is Nuveen Real Estate Income Fund a Buy, Sell or Hold?

  • The current Nuveen Real Estate Income Fund [JRS] share price is $7.57. The Score for JRS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • JRS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JRS Stock Price Chart

What is Nuveen Real Estate Income Fund's stock price today?

  • The Nuveen Real Estate Income Fund share price today is $7.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JRS is experiencing slight buying pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

JRS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 39.66 Sell
Chaikin Money Flow: -120747 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

JRS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.63 Sell
20-day SMA: 7.65 Sell
50-day SMA: 7.8 Sell
200-day SMA: 7.86 Sell
8-day EMA: 7.62 Sell
20-day EMA: 7.66 Sell
50-day EMA: 7.77 Sell
200-day EMA: 7.95 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

Nuveen Real Estate Income Fund Earnings Growth & JRS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

Nuveen Real Estate Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):